The treatment of Chagas disease patients with nitroderivative is unsatisfactory

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 43, Issue 3, 2001, Pages 175-181

  Lauria Pires, Liana ^a   Nitz, Nadjar ^a   De Vexenat, Ana Cássia ^a   Arganaraz, Enrique R ^a   D'Souza Ault, Marian ^a   Nascimento, Rubens J ^a   Tinoco, Douglas L ^a   Teixeira, Antonio R L ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; NIFURTIMOX; NITRO DERIVATIVE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHAGAS DISEASE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; ERADICATION THERAPY; HUMAN; LETTER; NONHUMAN; PERSISTENT INFECTION; SIDE EFFECT; TRYPANOSOMA CRUZI;

EID: 0034912520     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46652001000300013     Document Type: Letter

References (47)

1. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection
2. Myocardial parasite persistence in chronic chagasic patients
3. Mutagenicity of nitro- and amino-substituted carbazoles in Salmonella typhimurium. I. Monosubstituted derivatives of 9 H-carbazole
4. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas heart disease
5. Persistent infections in chronic Chagas disease patients treated with anti-Trypanosoma cruzi nitroderivatives
6. Clínica e terapêutica da doença de Chagas: Uma abordagem prática para o clínico geral
7. Criteria of Chagas disease cure
8. Forma aguda da Doença de Chagas no Brasil
9. Tratamento etiológico da Doença de Chagas pelo Benzonidazol
10. Specific treatment of human Chagas disease
11. Comparación de la mortalidad durante seguimento por 5 años en sujetos con enfermedad de Chagas cronica con y sin tratamiento de Benzonidazol
12. Results of anti Trypanosoma cruzi activity of Ro-7-1051 in man
13. Estudo comparativo controlado com emprego de benzonidazol, nifurtimox e placebo, na forma crônica da doença de Chagas, em uma área de campo com transmissão interrompida. I. Avaliação preliminar
14. Autoimmunity in Chagas disease: Biological relevance of a cardiac myosin-specific epitope cross-reactive to an immunodominant Trypanosoma cruzi antigen
15. Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity
16. Formation of DNA adducts and oxidative DNA damage in rats treated with 1,6-dinitropyrene
17. Generation of free radicals induced by nifurtimox in mammalian tissues
18. Tratamento específico na fase aguda da Doença de Chagas
19. Tratamento da forma indeterminada da Doença de Chagas com nifurtimox e benzonidazol
20. Mutagenicity of nifurtimox and benznidazole in the Salmonella-microsome assay
21. Experimental benznidazole encephalopathy. I. Clinical-neurological alterations
22. Experimental benznidazole encephalopathy. II. Electroencephalographic and morphological alterations
23. Validade do tratamento etiológico da fase crônica da doença de Chagas com benzonidazol
24. Etiological treatment for Chagas Disease
25. Respuesta al nifurtimox en pacientes de edad pediátrica con enfermedad de Chagas cronica de la ciudad de Buenos Aires, Argentina
26. Temporal comparisons of immune status and target organ histology in mice fed carcinogenic 5-nitrofurans and their nornitro analogs
27. Uso do benzonidazol em chagásicos na forma indeterminada: Resultados a longo prazo
28. Clinical, parasitological and histopathologic follow-up studies of acute Chagas patients treated with benznidazole
29. Induction of chromosomal gene mutations in Escherichia coli by direct incorporation of oxidatively damaged nucleotides. New evaluation method for mutagenesis by damaged DNA precursors in vivo
30. Interaction of nitroimidazole drugs with DNA in vitro: Structure-activity relationship
31. Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives
32. Influência da terapêutica específica na evolução da forma indeterminada da doença de Chagas
33. História natural da forma crônica da doença de Chagas. Tratamento específico
34. Chagas disease. Tropical Disease Research Progress 1991-1992
35. Cardiac involvement is a constant finding in acute Chagas disease: A clinical, parasitological and histopathological study
36. DNA damage induced in vivo by 7-methoxy-2-nitronaphto [2,1-b]-furan (R7000) in the lacI gene of Escherichia coli
37. Avaliação a longo prazo do tratamento específico na evolução clinica da forma indeterminada da doença de Chagas
38. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease
39. Chagas disease: Carcinogenic activity of the antitrypanosomal nitroarenes in mice
40. Chagas' disease: Lymphoma growth in rabbits treated with benznidazole
41. Malignant, non-Hodgkin's lymphomas in Trypanosoma cruzi-infected rabbits treated with nitroarenes
42. Mutagenicity and carcinogenicity of nitroarenes and their sources in the environment
43. DNA adducts in model systems and humans
44. Treatment of chronic Chagas disease with benznidazole: Clinical and serologic evolution of patients with long term follow-up
45. Biomonitoring of human exposure to carcinogenic nitroaromatic compounds: A pilot study on DNA adducts formation by 1,6-dinitropyrene in rats